- Recent Funding
- Investors
- TF Capital
TF Capital portfolio
TF Capital has 4 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.
About this page
Its most recent investment on record is Angitia Bio's $130M Series B+ round in February 2026, alongside Venrock Healthcare Capital Partners, Wellington Management, Morningside and 6 others. By category, its portfolio leans toward Health and bio (2) and Robotics and hardware (2). It has co-invested with Qiming Venture Partners, Elikon Venture and Octagon Capital Advisors, most often Qiming Venture Partners (2 rounds).
What TF Capital invests in
- Health and bio · 2 · 50%
- Robotics and hardware · 2 · 50%
- AI infrastructure and compute · 1 · 25%
- Climate and energy · 1 · 25%
TF Capital recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $130M | Venrock Healthcare Capital Partners (lead), Wellington Management, Morningside +6 | ||
| Series B+ · $1.4B | Samsung Electronics, SoftBank (lead), SE Ventures +6 | ||
| Series B+ · $50M | INCE Capital (lead), Elikon Venture, Octagon Capital Advisors +3 | ||
| Series A | Elikon Venture, Octagon Capital Advisors, FirstLight Capital +3 |
How TF Capital invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 3 75% | $1.58B |
| Series A | 1 25% | undisclosed |
TF Capital portfolio companies
AAngitia Bio$130MSeries B+ · Feb 2026
SSkild AI$1.4BSeries B+ · Jan 2026
AAllorion Therapeutics$50MSeries B+ · Mar 2023
EEfficient Computerbacker
| Company | Round with TF Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $130M | $130M | Feb 12, 2026 Series B+ |
Robotics and hardware |
Series B+ · $1.4B | $2.33B | Jan 14, 2026 Series B+ |
Health and bio |
Series B+ · $50M | $50M | Mar 10, 2023 Series B+ |
AI infrastructure and compute |
backer | $173M | Sep 29, 2026 Series B+ |
Most frequent co-investors
QQiming Venture Partners2 shared rounds · last Mar 10, 2023
- EElikon Venture2 shared rounds · last Mar 10, 2023
OOctagon Capital Advisors2 shared rounds · last Mar 10, 2023
RRA Capital Management1 shared round · last Feb 12, 2026
WWellington Management1 shared round · last Feb 12, 2026
OOrbiMed1 shared round · last Feb 12, 2026
LLogos Capital1 shared round · last Feb 12, 2026
MMorningside1 shared round · last Feb 12, 2026
LLegend Capital1 shared round · last Feb 12, 2026
JJanus Henderson Investors1 shared round · last Feb 12, 2026
YYonghua Capital1 shared round · last Feb 12, 2026
VVenrock Healthcare Capital Partners1 shared round · last Feb 12, 2026
Similar investors
AAble Partners4 companies · 1 deal in 12 mo
GGenoa Ventures5 companies · 4 deals in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
BBpifrance Digital Venture5 companies · 3 deals in 12 mo
CCatalyst Health Ventures5 companies · 3 deals in 12 mo
NNPIF – Mercia Equity Finance5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 4 rounds on Recent Funding that name TF Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists TF Capital, which is a subset of its real portfolio. API: /api/v1/investors/tf-capital (get a free API key). More: the most active VC firms and new venture capital funds.